Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia

Spector, Aimee; Thorgrimsen, Lene; Woods, Bob; Royan, Lindsay; Davies, Steve; Butterworth, Margaret; Orrell, Martin · 2003 · OpenAlex-citations

DOI: 10.1192/bjp.183.3.248

archive: archived pipeline: cataloged verified

Get this paper ↗ (DOI — opens at the source; we link to it, we don't host it)

Summary

This randomized controlled trial evaluated the efficacy of Cognitive Stimulation Therapy (CST), an evidence-based group intervention, for older adults with dementia. Motivated by a Cochrane review highlighting the need for large, well-designed trials to validate psychological treatments like reality orientation, the study aimed to determine if CST improved cognition and quality of life. The researchers developed CST based on prior pilot studies and systematic reviews, focusing on cognitive stimulation rather than factual orientation. The study employed a single-blind, multi-centre design involving 201 participants (115 in the intervention group, 86 in the control group) recruited from 23 residential homes and day centres. Participants met DSM-IV criteria for dementia and scored between 10 and 24 on the Mini-Mental State Examination (MMSE). The intervention consisted of 14 sessions, twice weekly for 45 minutes over seven weeks, featuring activities such as word games, reminiscence, and sensory stimulation. Control participants continued with usual activities, which often included minimal engagement. Assessments were conducted by masked researchers at baseline and follow-up. Primary outcomes included changes in cognitive function (MMSE and Alzheimer’s Disease Assessment Scale–Cognition [ADAS-Cog]), while secondary outcomes measured quality of life (QoL-AD), communication, behavior, anxiety, and depression. Data were analyzed using analysis of covariance (ANCOVA) to control for baseline variability. Results indicated that the intervention group showed statistically significant improvements compared to the control group on the MMSE (P=0.044), ADAS-Cog (P=0.014), and QoL-AD (P=0.028). Specifically, 30% of the treatment group improved by four or more points on the ADAS-Cog, yielding a number needed to treat (NNT) of 6. There was a non-significant trend toward improved communication (P=0.09), but no significant differences were found in behavior, anxiety, or depression. Attendance was high, with a mean of 11.6 sessions attended. The authors conclude that CST offers significant benefits for cognition and quality of life in people with dementia. The NNT of 6 for cognitive improvement compares favorably with trials of antidementia drugs, suggesting that CST is a viable and potentially more effective non-pharmacological intervention. The findings support the implementation of structured cognitive stimulation groups in care settings to enhance patient outcomes.

Provenance

The full processing record for this entry. Every stage of this paper's journey through the pipeline is logged — what ran, with which tool and model, how many attempts it took, and when it last completed.

StageOutcomeToolModelPromptAttemptsCompleted
discover success OpenAlex-citations 1 2026-06-19
archive success unpaywall 2 2026-06-26
extract success cached 2 2026-06-26
clean success clean 1 2026-06-19
chunk success chunk 1 2026-06-19
embed success embed Qwen/Qwen3-Embedding-8B 1 2026-06-19
promote success 1 2026-06-19
summarize success llm qwen3.6-27b-prismaquant summ-v5 1 2026-06-26
tag success vector_similarity 6 2026-06-19
verify success 1 2026-06-26

Summary generated by qwen3.6-27b-prismaquant on 2026-06-26; verification: verified.

Topics

Ranked by relevance to this paper. Hover a topic for its definition.